- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03521310
Immediate Parent -Infant Skin-to-Skin Study (IPISTOSS)
The World Health Organization recommend all stable low birth weight neonates to have Skin-to-skin-Contact (SSC) after birth. Intermittent SSC is used in Sweden in neonatal units. Observations indicate that SSC makes neonates feel good. However, there is limited research done on SSC treatment on neonates born prior to week 33.
The aim of this study is to investigate whether Skin-to-skin-Contact (SSC) leads to an improved physiological stabilization, altered epigenetic profile and improved longterm psychomotor outcome in neonates born in gestation age between week 28+0 - 32+6. This is a parallel, two-arm, multicentre, randomized controlled superiority trial. The two arms to be compared are a) immediate SSC with one parent/caregiver continous during the first 6 hours after birth and as much as possible during the first 72 hours, and b) conventional method of care during the same time.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Born in gestation week plus days 28+0 - 32+6.
- Born at maternity ward at study center
- Consent from parents/caregivers
- Parent or caregiver or substitute are available to start skin-to-skin Contact during the first hour of life.
Exclusion Criteria:
- Born outside the hospital
- Triplets or more
- Known malformation which will require immediate surgical action
On-going resuscitation or intensive Medical care (mechanic ventilation or inotropy) after the first lifespan
* Known congenital infection
- Parent/care giver can not communicate in Swedish/Norwegian or English
- Not suited for the study for other reasons (according to the principal investigator)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Skin-to-skin Contact group
Neonates in gestational age between 28+0 - 32+6 will get continuous Skin-to-skin contact with one parent/caregiver the first 6 hours after birth and as much as possible the first 72 hours after birth.
|
Neonates will get Skin-to-skin Contact with parent/caregiver continuously the first 6 hours after birth and as much as possible the first 72 hours after birth.
|
|
ACTIVE_COMPARATOR: Conventional care group
Neonates in gestational age between 28+0 - 32+6 will get Conventional care - incubators, warmers etc - the first 72 hours after birth.
|
Neonates will get Conventional care the first 72 hours after birth
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cardiorespiratory stability
Time Frame: After six hours
|
Using the Stability of the CardioRespiratory system In the Preterm-score (SCRIP-score).
A higher SCRIP score indicates greater physiological stability
|
After six hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Need for respiratory support
Time Frame: After 3 months
|
Days in respirator from birth to discharge from hospital
|
After 3 months
|
|
Need for surfactant
Time Frame: After 3 months
|
Number of doses of surfactants from birth to discharge from hospital,
|
After 3 months
|
|
Need of Continuous positive airway pressure
Time Frame: After 3 months
|
Days in use of Continuous positive airway pressure (CPAP)- from birth to discharge from hospital
|
After 3 months
|
|
Need for oxygen
Time Frame: After 3 months
|
Days in use of oxygen from birth to discharge from hospital
|
After 3 months
|
|
Heart Rate Variability
Time Frame: Up to 3-4 months
|
Up to 3-4 months
|
|
|
Body temperature
Time Frame: At 0 hour (postpartum), 1, 2, 3, 4, 5 and 6 hours
|
Axillary body temperature
|
At 0 hour (postpartum), 1, 2, 3, 4, 5 and 6 hours
|
|
Sepsis episodes
Time Frame: After 3 months
|
Number of Sepsis episodes from birth to discharge from hospital, based on the Medical records
|
After 3 months
|
|
Number of Antibiotic treatment
Time Frame: After 3 months
|
Number of Days with antibiotic treatment from birth to discharge from hospital based on Medical records
|
After 3 months
|
|
Status of Breast-feeding
Time Frame: Up to12 months
|
Status of Breast-feeding according to a specific questionnaire: Index of Breastfeeding (IBS)
|
Up to12 months
|
|
Status of Breast-feeding
Time Frame: Up to12 months
|
Status of Breast-feeding according to a specific questionnaire: Breastfeeding Self efficacy Questionnaire (BSES)
|
Up to12 months
|
|
Status of Breast-feeding
Time Frame: Up to12 months
|
Status of Breast-feeding according to a specific questionnaire: Infant Breastfeeding Assessment Tool (IBFAT).
|
Up to12 months
|
|
Time to Full enteral nutrition
Time Frame: After 3 months
|
Days from birth until Full enteral nutrition
|
After 3 months
|
|
Time in use of Nasogastric tube feeding
Time Frame: After 3 months
|
Days from birth in use of Nasogastric tube feeding
|
After 3 months
|
|
Time to recovered birth weight
Time Frame: After 3 months
|
Days from birth until recovered birth weight
|
After 3 months
|
|
Weight gain
Time Frame: Up to 12 months
|
Weight gain from birth
|
Up to 12 months
|
|
Epigenetic profiling in buccal cells
Time Frame: Up to 24 months
|
Whole-genome methylation analysis and locus specific analysis of selected stress related genes, will be conducted to investigate early, intermediate and long-term epigenetic changes due to the intervention.
|
Up to 24 months
|
|
Telomere profiling in buccal cells
Time Frame: Up to 24 months
|
Whole-genome methylation analysis and locus specific analysis of selected stress related genes, will be conducted to investigate telomere length.
|
Up to 24 months
|
|
Epigenetic profiling in blood samples
Time Frame: Up to 24 months
|
Whole-genome methylation analysis and locus specific analysis of selected stress related genes, will be conducted to investigate early, intermediate and long-term epigenetic changes due to the intervention.
|
Up to 24 months
|
|
Telomere profiling in blood samples
Time Frame: Up to 24 months
|
Whole-genome methylation analysis and locus specific analysis of selected stress related genes, will be conducted to investigate telomere length
|
Up to 24 months
|
|
Microbiota
Time Frame: 0-6 hours, 72 hours, 3-4 months, 12 and 24 months. Mother is tested at 0-6 hours and partner with skin swabs at 0-6 hours.
|
The child's colonization with bacteria is identified by DNA-analysis from stool samples, nasal and skin swabs, compared with parents (mother is tested by vaginal, rectal, nasal and skin swabs.
|
0-6 hours, 72 hours, 3-4 months, 12 and 24 months. Mother is tested at 0-6 hours and partner with skin swabs at 0-6 hours.
|
|
Maturation of EEG-pattern
Time Frame: Postnatal day 4-10 and postmenstrual age of 40-42 weeks
|
Postnatal day 4-10 and postmenstrual age of 40-42 weeks
|
|
|
Structural and functional maturation of the infant brain
Time Frame: At term age
|
Magnetic Resonance Imaging scans will be performed with a 3 Tesla machine.
Three-dimensional and diffusion sequences as well as functional MRI (fMRI) sequences will be performed in order to examine structural and functional maturation respectively.
Structural sequences are used to study the different tissues of the brain; diffusion images give information about the connections of the brain (white matter) and fMRI gives information on how the brain integrates information to perform a specific function.
|
At term age
|
|
Maternal brain responsiveness
Time Frame: At 4 months
|
The maternal brain responses will be evaluated by using structural and functional magnetic resonance imaging to measure structural changes on social, emotional and behavioural networks as well as the cerebral response of mothers viewing neutral, happy and distress face images of their own infant, along with a matched unknown infant.
We will use a 3 Tesla machine.
We will study cortical and subcortical networks related with the emotional, social and behavioral responses involving the mother-child interactions and responses, such as the insula, the cingulate cortex, the precentral gyrus, the right orbital gyrus, the inferior, middle and superior frontal gyrus the fusiform gyrus, supramarginal gyrus, the superior parietal gyrus, the inferior temporal gyrus, and basal ganglia among others.
|
At 4 months
|
|
Bonding and interaction between parent and child
Time Frame: At 3-4 months and at 12 and 24 months.
|
A videotaped mother-infant interaction session will be assessed through with the Parent-Child Early Relational Assessment (PCERA)
|
At 3-4 months and at 12 and 24 months.
|
|
Bonding and interaction between parent and child
Time Frame: At 3-4 months
|
A videotaped mother-infant interaction session will be assessed through the "Still Face situation"
|
At 3-4 months
|
|
Parents' experiences
Time Frame: Up to 12 months
|
Parents will fill in the following questionnaire: State-Trait Anxiety Index(STAI)
|
Up to 12 months
|
|
Parents' experiences
Time Frame: Up to 12 months
|
Parents will fill in the following questionnaire: Swedish Parenting Questionnaire (SPSQ)
|
Up to 12 months
|
|
Parents' experiences
Time Frame: Up to 12 months
|
Parents will fill in the following questionnaire: Edinburgh postnatal Depression Scale (EPDS)
|
Up to 12 months
|
|
Maternal-Child physiological attunement in stress regulation
Time Frame: In the morning and in the evening at the day of discharge, At the day of discharge before and after diaper change, at 3-4 months, at the same day as Still Face-test before and after, at 12 months.
|
Saliva Cortisol both mother and child
|
In the morning and in the evening at the day of discharge, At the day of discharge before and after diaper change, at 3-4 months, at the same day as Still Face-test before and after, at 12 months.
|
|
Neuro Behaviour of Child
Time Frame: At term age, at 3-4, 12 and 24 months
|
According to records and to questionnaires for example Infant Behavior Questionnaire (IBQ)
|
At term age, at 3-4, 12 and 24 months
|
|
Neuro Behaviour of Child
Time Frame: At term age, at 3-4, 12 and 24 months
|
According to records and to questionnaires for example Bayley Scales
|
At term age, at 3-4, 12 and 24 months
|
|
Neuro Behaviour of Child
Time Frame: At term age, at 3-4, 12 and 24 months
|
According to records and to questionnaires for example Ages and Stages Questionnaire (ASQ)
|
At term age, at 3-4, 12 and 24 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Chair: Björn Westrup, MD,PhD, Department of Women´s and Children´s Health, Karolinska Institutet, Stockholm, Sweden
- Principal Investigator: Siren Rettedal, MD, PhD, Stavanger University hospital, Stavanger, Norway
- Principal Investigator: Wibke Jonas, Ass prof, Department of Women´s and Children´s Health, Karolinska Institutet, Stockholm, Sweden
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IPISTOSS
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.